Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Novo Nordisk to open $130 million diabetes labs

November 3, 2014 Manufacturing and Production, Sales and Marketing Denmark, Måløv, Novo Nordisk, Tresiba, Victoza, diabetes

Novo Nordisk has invested $130 million in new diabetes laboratories as the company looks to focus more strongly on the …
News

UK doctors are ignoring statin guidance

November 3, 2014 Sales and Marketing British Medical Association, GPs, NHS, NICE, Royal College of GPs, Royal College of Physicians, statins

A survey of UK doctors has found that many are refusing to apply NICE advice to offer statin therapy to …
News

Growing IPF drugs market evident at ERS Congress

November 3, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ERS, Esbriet, IPF, elf, european respiratory society, ofev

Arriving in Germany for this year’s European Respiratory Society (ERS) International Congress 2014, what awaited Pharmafile at the Ausgang was …
Feature

Takeda hires Merck senior head as president

November 3, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, marc princen

Marc Princen has joined Takeda Pharmaceuticals from Merck and is to serve as its corporate officer and president of the …
Appointment

AbbVie financials beat expectations

October 31, 2014 Sales and Marketing AbbVie, Abbott, Creon, Humira, Iopinavir/ritonavir, Kaletra, Q3, Synthroid, levothyroxine, pancrelipase

AbbVie has announced higher-than-expected financial results for the third quarter of 2014, although it continues to rely heavily on blockbuster …
News

BMS and Lonza announce expansion plans

October 31, 2014 Manufacturing and Production, Sales and Marketing BMS, Lonza, Orencia, manufacturing, opdivo

Bristol-Myers Squibb (BMS) and Lonza are to expand upon an existing manufacturing agreement to meet anticipated demand for commercial biologics. …
News

NICE recommends new indication for troubled Pradaxa

October 31, 2014 Sales and Marketing Boehringer, NHS, NICE, Pradaxa, dabigatran, ingelheim, warfarin

NICE has recommended Boehringer Ingelheim’s controversial anti-blood clotting drug Pradaxa for treating and preventing potentially-fatal blood clots in the legs …
News

BMS lung cancer drug scores in Phase II

October 31, 2014 Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, FDA, NSCLC, bristol myers-squibb, odivo

Bristol-Myers Squibb is still in the hunt to gain significant market share in the PD-1 therapeutic vaccine race after releasing …
News

More cancer patients surviving for longer

October 31, 2014 Medical Communications, Research and Development, Sales and Marketing Cancer, bladder, breast, myeloma, oncology, ons, prostate

Cancer survival rates in England are continuing to improve, though many cancers still have an ‘extremely poor’ prognosis, according to …
News

Carmago hires drug development head

October 31, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing carmago, steven castillo

US drug development firm Camargo Pharmaceutical Services has expanded its leadership team with the appointment of Steven Castillo as vice …
Appointment

Microsoft enters into wearables market

October 30, 2014 Medical Communications, Sales and Marketing Apple, Microsoft, band, fitness, health, watch, wearable, wearables

Microsoft has launched a new wearable heath tracking device as it looks to battle with Apple and Samsung in an …
News

Two neuroscientists join Biogen Idec

October 30, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, richard ransohoff

Christopher Henderson and Richard Ransohoff have joined Biogen Idec to lead the company’s neurology research and discovery efforts. Henderson joins …
Appointment

Takeda and Lilly get Actos trial reprieve

October 29, 2014 Sales and Marketing Actos, Takeda, bladder cancer, diabetes, lilly

A judge has dramatically reduced the $9 billion damages bill Takeda and Lilly were set to pay over safety allegations …
News

Sovaldi misses estimates but still makes history

October 29, 2014 Research and Development, Sales and Marketing FDA, Gilead, harvoni, hep C, sofosbuvir, sovaldi

The trajectory of Gilead’s new hep C pill Sovaldi has slowed but the drug is still on course to break …
News

Sanofi’s chief executive ousted

October 29, 2014 Medical Communications, Research and Development, Sales and Marketing Christopher Viehbacher, Sanofi

Sanofi’s chief executive Chris Viehbacher has been ejected from his role after the French firm’s board lost patience with his …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026